Suscribirse

Coronary Artery Calcium and the Age-Specific Competing Risk of Cardiovascular Versus Cancer Mortality: The Coronary Artery Calcium Consortium - 28/09/20

Doi : 10.1016/j.amjmed.2020.02.034 
Seamus P. Whelton, MD, MPH a, , Mahmoud Al Rifai, MD, MPH a, Catherine Handy Marshall, MD, MPH a, b, Zeina Dardari, MS a, Leslee J. Shaw, PhD c, Mouaz H. Al-Mallah, MD d, Alan Rozanski, MD e, Martin B. Mortensen, MD PhD f, Omar Dzaye, MD PhD a, Lydia Bazzano, MD, PhD g, Tanika N. Kelly, PhD, MPH g, Kunihiro Matsushita, MD, PhD h, John A. Rumberger, MD, PhD i, Daniel S. Berman, MD j, Matthew J. Budoff, MD k, Michael D. Miedema, MD l, Khurram Nasir, MD, MPH a, m, Michael J. Blaha, MD, MPH a
a Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, Md 
b Sidney Kimmel Comprehensive Cancer Center, Baltimore, Md 
c Weill Cornell Medical College, New York, NY 
d Houston Methodist Hospital, Houston, TX 
e Division of Cardiology, Mount Sinai, St Luke's Hospital, New York, NY 
f Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark 
g Tulane University School of Public Health and Tropical Medicine, New Orleans, La 
h Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md 
i Princeton Longevity Center, Princeton, NJ 
j Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, Calif 
k Department of Medicine, Harbor UCLA Medical Center, Los Angeles, Calif 
l Minneapolis Heart Institute and Foundation, Minneapolis, Minn 
m Center for Outcomes Research and Evaluation, Yale University, New Haven, Conn 

Requests for reprints should be addressed to Seamus P. Whelton, MD, MPH, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287.600 North Wolfe Street, Blalock 524ABaltimoreMD21287

Abstract

Background

Coronary artery calcium (CAC) is a guideline recommended cardiovascular disease (CVD) risk stratification tool that increases with age and is associated with non-cardiovascular disease outcomes including cancer. We sought to define the age-specific change in the association between CAC and cause-specific mortality.

Methods

The Coronary Artery Calcium Consortium includes 59,502 asymptomatic patients age 40-75 without known CVD. Age-stratified mortality rates and parametric survival regression modeling was performed to estimate the age-specific CAC score at which CVD and cancer mortality risk were equal.

Results

The mean age was 54±8 years (67% men) and there were 2,423 deaths over a mean 12±3 years follow-up. Among individuals with CAC = 0, cancer was the leading cause of death, with low CVD mortality rates for both younger (40-54 years) 0.2/1,000 person-years and older participants (65-75 years) 1.3/1,000 person-years. When CAC ≥400, CVD was consistently the leading cause of death among younger (71% of deaths) and older participants (56% of deaths). The CAC score at which CVD overtook cancer as the leading cause of death increased exponentially with age and was approximately 115 at age 50 and 380 at age 65.

Conclusions

Regardless of age, when CAC = 0 cancer was the leading cause of death and the cardiovascular disease mortality rate was low. Our age-specific estimate for the CAC score at which CVD overtakes cancer mortality allows for a more precise approach to synergistic prediction and prevention strategies for CVD and cancer.

El texto completo de este artículo está disponible en PDF.

Keywords : Age, Competing risk, Coronary artery calcium, Risk prediction


Esquema


 Funding: SPW was supported by the American Heart Association Mentored Clinical and Population Research Award (17MCPRP33660247) and the PJ Schafer Memorial Foundation.
 Conflict of Interest: LJS has received grant support from the Antinori Foundation. MJ Budoff has received grant support from GE Healthcare. CHM has received grant support from Bristol Myers Squibb and travel support from DAVA Oncology. She also reports being a consultant for McGraw-Hill. All other authors have nothing to disclose.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2020  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 133 - N° 10

P. e575-e583 - octobre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes
  • Christian D. Becker, Ralph L. Sabang, Monica F. Nogueira Cordeiro, Ibrahim F. Hassan, Michael D. Goldberg, Corey S. Scurlock
| Artículo siguiente Artículo siguiente
  • Sleeping with Elevated Upper Body Does Not Attenuate Acute Mountain Sickness: Pragmatic Randomized Clinical Trial
  • Ulrich Limper, Vera Fiala, Jens Tank, Eva-Maria Elmenhorst, Gereon Schaelte, Ya-Yu Monica Hew, Peter Gauger, Peter Martus, Jens Jordan

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.